A Review of Cardiac Complications in Coronavirus Disease 2019

Curēus
Romil SinghSalim Surani

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has shown an association with acute myocardial injury, cardiomyopathy, and myocarditis. Individuals with myocardial involvement in association with the coronavirus disease 2019 (COVID-19) may be at increased risk of developing severe illness. Cardiomyopathies are a heterogeneous group of diseases of the myocardium associated with mechanical and/or electrical dysfunction that usually exhibit inappropriate ventricular hypertrophy or dilation and are due to a variety of causes that frequently are genetic. It has been primarily divided into three subsets: genetic, mixed, and acquired cardiomyopathy. We anticipate that, because of the high inflammatory response, other cardiovascular complications may also occur in COVID-19 patients with severe symptoms. This review explores new information as it pertains to COVID-19 and cardiac complications.

Citations

Feb 16, 2021·Frontiers in Cardiovascular Medicine·Ashraf RoshdyJohn Gerry Coghlan
Sep 1, 2021·Curēus·Amr SalehRahul Kashyap

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Life Sciences
Savalan Babapoor-FarrokhranAman Amanullah
The American Journal of the Medical Sciences
Wei-Ting ChangWen-Liang Yu
The American Journal of Emergency Medicine
Brit LongMichael Gottlieb
Current Cardiology Reports
Nicolas L PalaskasAnita Deswal
© 2022 Meta ULC. All rights reserved